KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Long-Term Deferred Tax (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Long-Term Deferred Tax readings, the most recent being $2.2 billion for Q1 2026.

  • On a quarterly basis, Long-Term Deferred Tax rose 24.29% to $2.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $2.2 billion, a 24.29% increase, with the full-year FY2025 number at $2.2 billion, up 21.79% from a year prior.
  • Long-Term Deferred Tax hit $2.2 billion in Q1 2026 for Teva Pharmaceutical Industries, roughly flat from $2.2 billion in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $2.2 billion in Q4 2025 to a low of $637.0 million in Q1 2022.
  • Median Long-Term Deferred Tax over the past 5 years was $1.8 billion (2025), compared with a mean of $1.7 billion.
  • Biggest five-year swings in Long-Term Deferred Tax: skyrocketed 148.55% in 2022 and later decreased 21.06% in 2025.
  • Teva Pharmaceutical Industries' Long-Term Deferred Tax stood at $1.5 billion in 2022, then increased by 24.28% to $1.8 billion in 2023, then fell by 0.72% to $1.8 billion in 2024, then increased by 21.79% to $2.2 billion in 2025, then dropped by 0.05% to $2.2 billion in 2026.
  • The last three reported values for Long-Term Deferred Tax were $2.2 billion (Q1 2026), $2.2 billion (Q4 2025), and $1.6 billion (Q3 2025) per Business Quant data.